Elmar R. Burchardt
Corporate Officer/Principal chez University of Witten/Herdecke
Profil
Elmar R.
Burchardt is currently an Associate Professor at the University of Witten.
Previously, he held positions as the Chief Executive Officer & Director at TheraVitae, Inc., President, Chief Executive Officer & Director at Hemostemix, Inc., Medical Director at Miltenyi GmbH, Vice President-Medical Affairs at Vericel Corp., and Senior Research Group Leader at Bayer AG.
He obtained his graduate and doctorate degrees from Hannover Medical School.
Postes actifs de Elmar R. Burchardt
Sociétés | Poste | Début |
---|---|---|
University of Witten/Herdecke | Corporate Officer/Principal | - |
Anciens postes connus de Elmar R. Burchardt
Sociétés | Poste | Fin |
---|---|---|
HEMOSTEMIX INC. | Directeur Général | 25/01/2017 |
VERICEL CORPORATION | Directeur Technique/Scientifique/R&D | 30/05/2010 |
TheraVitae, Inc.
TheraVitae, Inc. BiotechnologyHealth Technology TheraVitae, Inc. developed and commercialized adult stem cell technologies. Its products were used to treat cardiovascular diseases. The company was headquartered in Toronto, Canada. | Directeur Général | - |
Miltenyi GmbH
Miltenyi GmbH Financial ConglomeratesFinance Miltenyi Biotec GmbH provides biotechnology products and services. The firm products include MACS sample preparation, MACS cell separation, MACS flow cytometry, MACS cell culture and stimulation and MACS molecular; research areas include immunology, stem cell research, neuroscience, and cancer research. Its clinical applications include clinical development, CliniMACS system, MACS GMP products, CryoMACS freezing products, TheraSorb, graft engineering, immunotherapy, tissue regeneration and freezing products. The company was founded by Stefan Miltenyi in 1989 and is headquartered in Teterow, Germany. | Directeur Technique/Scientifique/R&D | - |
BAYER AG | Corporate Officer/Principal | - |
Formation de Elmar R. Burchardt
Hannover Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
VERICEL CORPORATION | Health Technology |
BAYER AG | Health Technology |
HEMOSTEMIX INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Miltenyi GmbH
Miltenyi GmbH Financial ConglomeratesFinance Miltenyi Biotec GmbH provides biotechnology products and services. The firm products include MACS sample preparation, MACS cell separation, MACS flow cytometry, MACS cell culture and stimulation and MACS molecular; research areas include immunology, stem cell research, neuroscience, and cancer research. Its clinical applications include clinical development, CliniMACS system, MACS GMP products, CryoMACS freezing products, TheraSorb, graft engineering, immunotherapy, tissue regeneration and freezing products. The company was founded by Stefan Miltenyi in 1989 and is headquartered in Teterow, Germany. | Finance |
TheraVitae, Inc.
TheraVitae, Inc. BiotechnologyHealth Technology TheraVitae, Inc. developed and commercialized adult stem cell technologies. Its products were used to treat cardiovascular diseases. The company was headquartered in Toronto, Canada. | Health Technology |